The Valley Desk

NCT04300140 · Interventional trial

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Clear Cell Renal Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov